We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$243M
AUM Growth
+$124M
Cap. Flow
+$129M
Cap. Flow %
53.22%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
+$71.8M
2
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$59.5M

Top Sells

Rank Stock Value
1
TARA icon
Protara Therapeutics
TARA
+$2.23M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYTM icon
1
Rhythm Pharmaceuticals
RYTM
$7.07B
$84.3M 34.75%
3,074,893
– –
TCRR
2
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$70.6M 29.11%
+4,050,865
New +$71.8M
HARP
3
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$42.8M 17.67%
+452,443
New +$59.5M
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
$29.8M 12.3%
5,736,296
– –
SNDX icon
5
Syndax Pharmaceuticals
SNDX
$1.84B
$11.4M 4.7%
2,168,691
– –
HSTO
6
DELISTED
Histogen Inc. Common Stock
HSTO
$2.66M 1.1%
12,324
– –
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
$900K 0.37%
250,000
– –
TARA icon
8
Protara Therapeutics
TARA
$233M
– –
-24,585
Closed -$2.23M

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, MPM Asset Management held 8 positions worth $243M, up 105% from $118M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management deployed $129M of net new capital in Q1 2019, opening 2 new positions. Its largest new stake was TCR2 Therapeutics Inc. Common Stock: 4,050,865 shares worth $70.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Protara Therapeutics, an estimated $2.23M sold.

  • MPM Asset Management's largest Q1 2019 buy was TCR2 Therapeutics Inc. Common Stock: 4,050,865 shares worth $70.6M.
  • MPM Asset Management fully exited Protara Therapeutics in Q1 2019, selling an estimated $2.23M.
  • MPM Asset Management's ten largest holdings make up 100% of its $243M portfolio in Q1 2019.
  • MPM Asset Management opened 2 new positions and closed 1 in Q1 2019.
  • MPM Asset Management's portfolio value rose 105% quarter-over-quarter to $243M.

Based on MPM Asset Management's 13F filing for Q1 2019, filed 13 May 2019.